Clinical Trials Logo

Neural Tube Defects clinical trials

View clinical trials related to Neural Tube Defects.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06174883 Completed - Spina Bifida Clinical Trials

Salt-FA to Increase Folate Levels

Start date: June 1, 2022
Phase:
Study type: Observational

Question: How effective is folic acid-fortified iodized salt in increasing serum folate concentrations among non-pregnant and non-lactating women of reproductive age? Hypothesis: Folic acid-fortified iodized salt can increase serum folate levels and serve as a policy consideration in salt fortification with both iodine and folic acid to reduce serious and fatal birth defects.

NCT ID: NCT06135883 Completed - Neural Tube Defects Clinical Trials

Assessing Folic Acid in High-Risk Pregnancy for Neural Tube Defects

Start date: February 20, 2023
Phase:
Study type: Observational [Patient Registry]

Aim of this study is to investigate and statistically reveal the prevalence and awareness of folic acid usage in pregnant women who have at least one of the risk factors for neural tube defects, to express the level of knowledge of the determined population on this subject and to present ideas to increase awareness in the society.

NCT ID: NCT05935631 Completed - Neural Tube Defects Clinical Trials

Feasibility, Acceptability and Directional Signal Effect on Blood Folate Levels of Iodized Salt Fortified With Folic Acid: Clinical Study

FASALT
Start date: January 24, 2023
Phase: N/A
Study type: Interventional

Aim 1: Assess directional signal of effect of fortified salt with folic acid and iodine on blood serum folate levels. It will be accomplished by feasibility pre-test/post-test clinical study by estimating mean and variability of serum blood folate levels effects of folic acid fortified salt. Hypothesis: Fortified salt with folic acid and iodine will increase serum blood folate levels from baseline by month 1. Aim 2: Assess feasibility and acceptability of salt fortified with folic acid and iodine. Feasibility will be measured by 1) subjects' refusal rate of consent by 30 subjects during 6-month enrollment period; 2) method of determining salt consumption (weighting the saltshaker pre and post); 3) completion rates of study protocols from baseline to follow up. Hypothesis 1a: Completion of all blood draw visits will be 90-100%. Acceptability will be measured by 1) completion rate of daily salt logs; 2) consumption of salt by weighting saltshakers; 3) attitude towards taste and color difference. Hypothesis 1b: Completion rate (90-100%) of daily salt logs will range from 90-100% of participants and 2) consumption of salt will range from 90-100% of participants. Dietary surveys will be employed to document dietary habits and estimated daily FA intake in the sample population. Feasibility and acceptability of dietary surveys will be measured by willingness to answer survey questions. Hypothesis 1c: Completion rate of dietary surveys will range 90-100%.

NCT ID: NCT05883761 Completed - Clinical trials for Congenital Abnormalities

Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment

Start date: September 7, 2021
Phase:
Study type: Observational

The goal of this observational study is to assess the birth outcomes of HIV-positive women delivering in hospitals in Eswatini who are receiving dolutegravir (DTG) or other anti-retroviral (ARV) drug regimens. The main question the study aims to answer is, what is the proportion of neural tube defects among live and stillborn infants delivered by: - HIV-positive women on DTG at conception - HIV-negative women - HIV-positive women on non-DTG ARV at conception Participants will be interviewed for information on HIV testing and antiretroviral therapy history, other medical history of selected conditions (e.g., diabetes, malaria, TB) and potential birth defect exposures. Photographs will be taken of the infants. Data on mothers' pregnancy history, birth outcomes, and HIV and ARV information (as applicable) will be collected from patient records.

NCT ID: NCT05454085 Completed - Neural Tube Defects Clinical Trials

Could Bisphenol-A Have a Role in the Etiology of Neural Tube Defects

Start date: April 15, 2021
Phase: N/A
Study type: Interventional

Our aim in this study is in patients with a diagnosis of neural tube defect; is the measurement of BPA levels in maternal blood and amniotic fluid.

NCT ID: NCT04483570 Completed - Neurogenic Bladder Clinical Trials

Urological Deterioration in Secondary Tethered Cord Syndrome and Clue to Detect It

Start date: January 2011
Phase:
Study type: Observational

Secondary tethered cord syndrome (STCS) has been diagnosed with signs of progressive deterioration in urological or neuroorthopedic systems following primary tethering surgery. However, there is no convincing urological diagnostic clue for STCS.

NCT ID: NCT04195542 Completed - Clinical trials for Spina Bifida or Spinal Dysraphism

Vitamin B9 Supplementation Recommendations in Rennes CHU

QUALI B9
Start date: September 24, 2019
Phase:
Study type: Observational

The study objective is to assess the knowledge and the follow-up of vitamin B9 supplementation recommendations for women in the periconceptional period to prevent neural tube closure defects. It will be conducted with health professionnals and women who have just given birth in Rennes CHU. This study aimes to assess men's and women's knowledge of the need to take vitamin B9 supplementation in women in the periconceptional period and the reasons why this supplementation is carried out or not, in order to target our future prevention campaign. This will allow comparing the results before and after the prevention campaign.

NCT ID: NCT04135274 Completed - Neural Tube Defects Clinical Trials

Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?

Start date: January 1, 2015
Phase:
Study type: Observational [Patient Registry]

We aimed to investigate whether Neutrophil Lymphocyte Ratio is a Prognostic Factor of Sepsis in Newborns with operated Neural Tube Defects?

NCT ID: NCT03544970 Completed - Fetal Anomaly Clinical Trials

An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience

Start date: April 1, 2017
Phase:
Study type: Observational

Brain stem and posterior fossa measurements in spina bifida aperta fetuses to compare them with normal population. Additionally, Describe the difference between pre- and postoperative findings.

NCT ID: NCT01743196 Completed - Obesity Clinical Trials

Folate Metabolism in Normal Weight and Obese Women of Child-bearing Age

Start date: May 2012
Phase: N/A
Study type: Observational

The purpose of this study is to determine if there is a difference in the short term response in serum folate after a single dose of folic acid in normal weight and obese women of childbearing age.